| Title: |
Effect of post-study immunotherapy (IO) on overall survival (OS) outcome in patients with metastatic (m) NSCLC treated with first-line durvalumab (D) vs chemotherapy (CT) in the phase III MYSTIC study |
| Authors: |
Reinmuth, N.; Cho, B.C.; Lee, K.H.; Luft, A.; Ahn, M.-J.; Schneider, J.; Shepherd, F.A.; Geater, S.L.; Pápai-Székely, Z.; Van Ngoc, T.; Garassino, M.C.; Liu, F.; Clemett, D.; Thiyagarajah, P.; Ouwens, M.; Scheuring, U.; Peters, S.; Rizvi, N. |
| Source: |
Annals of Oncology ; volume 30, page ii77 ; ISSN 0923-7534 |
| Publisher Information: |
Elsevier BV |
| Publication Year: |
2019 |
| Collection: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1093/annonc/mdz094.003 |
| Availability: |
http://dx.doi.org/10.1093/annonc/mdz094.003; https://api.elsevier.com/content/article/PII:S0923753419302625?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S0923753419302625?httpAccept=text/plain; http://academic.oup.com/annonc/article-pdf/30/Supplement_2/mdz094/28356007/mdz094.pdf |
| Rights: |
https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| Accession Number: |
edsbas.E291F56A |
| Database: |
BASE |